Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 3 Breast Neoplasms 3 Neoplasm Metastasis 2 Bone Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Pancreatic Neoplasms 1 Melanoma 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Abdominal Pain 1

Interventions

Doxorubicin 27 Cyclophosphamide 26 Radiotherapy 16 Gemcitabine 16 Filgrastim 11 pembrolizumab 10 pazopanib 10 Radiation 9 Docetaxel 9 Cisplatin 9 fludarabine 7 Trabectedin 7 Ipilimumab 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Carboplatin 7 Busulfan 7 Bevacizumab 7 olaratumab 6 Temozolomide 6 Peripheral Blood Stem Cell Transplantation 6 Nivolumab 6 Mesna 6 Melphalan 6 selinexor 5 Leucovorin 5 Irinotecan 5 Celecoxib 5 Bortezomib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × Cryosurgery × Clear all

NCT00002863 2014-05-22

Cryosurgery in Treating Patients With Soft Tissue Sarcoma

University of Southern California

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡